Search Results - "Bollaerts A"

Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: Proceedings from the First Beyond COVID-19 Monitoring Excellence (BeCOME) Conference: Multi-Stakeholder Call to Action for the Future of Vaccine Post-Marketing Monitoring: V. Bauchau et al

Authors: Bauchau, Vincent Bollaerts, Kaatje Bryan, Phil et al.

Source: Drug Safety. May2025, Vol. 48 Issue 5, p577-585. 9p.

Disease misclassification in electronic healthcare database studies: Deriving validity indices—A contribution from the ADVANCE project.

Authors: Bollaerts, Kaatje Rekkas, Alexandros De Smedt, Tom et al.

Source: PLoS ONE. 4/22/2020, Vol. 15 Issue 4, p1-10. 10p.

Prior Exposure to Immunosuppressors Sensitizes Retinal Microglia and Accelerates Optic Nerve Regeneration in Zebrafish.

Authors: Bollaerts, Ilse Van houcke, Jessie Beckers, An et al.

Source: Mediators of Inflammation. 2/10/2019, p1-16. 16p.

This result is not displayed to guests.
Login for full access.

Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Authors: Riera-Montes, Margarita Bollaerts, Kaatje Heininger, Ulrich et al.

Source: BMC Infectious Diseases. 5/18/2017, Vol. 17, p1-16. 16p. 2 Diagrams, 10 Charts.

Neuroinflammation as Fuel for Axonal Regeneration in the Injured Vertebrate Central Nervous System.

Authors: Bollaerts, Ilse Van houcke, Jessie Andries, Lien et al.

Source: Mediators of Inflammation. 1/19/2017, p1-14. 14p.

Application of Probabilistic Multiple-Bias Analyses to a Cohort- and a Case-Control Study on the Association between Pandemrix^™and Narcolepsy.

Authors: Bollaerts, Kaatje Shinde, Vivek Dos Santos, Gaël et al.

Source: PLoS ONE. 2/22/2016, Vol. 11 Issue 2, p1-14. 14p.

Vaccine-Preventable Disease Incidence Based on Clinically, Radiologically, and Etiologically Confirmed Outcomes: Systematic Literature Review and Re-analysis of Pneumococcal Conjugate Vaccine Efficacy Trials.

Authors: Bollaerts, Kaatje Fletcher, Mark A Suaya, Jose A et al.

Source: Clinical Infectious Diseases. 4/15/2022, Vol. 74 Issue 8, p1362-1371. 10p.

Estimating the population prevalence and force of infection directly from antibody titres.

Authors: Bollaerts, K Aerts, M Shkedy, Z et al.

Source: Statistical Modelling: An International Journal. Oct2012, Vol. 12 Issue 5, p441-462. 22p.

Evaluation of Scenarios for Reducing Human Salmonellosis Through Household Consumption of Fresh Minced Pork Meat.

Authors: Bollaerts, Kaatje Messens, Winy Aerts, Marc et al.

Source: Risk Analysis: An International Journal. May2010, Vol. 30 Issue 5, p853-865. 13p. 2 Diagrams, 2 Charts, 1 Graph.

Development of a Quantitative Microbial Risk Assessment for Human Salmonellosis Through Household Consumption of Fresh Minced Pork Meat in Belgium.

Authors: Bollaerts, Kaatje Els Messens, Winy Delhalle, Laurent et al.

Source: Risk Analysis: An International Journal. Jun2009, Vol. 29 Issue 6, p820-840. 21p. 3 Diagrams, 4 Charts, 5 Graphs.

Human Salmonellosis: Estimation of Dose-Illness from Outbreak Data.

Authors: Bollaerts, Kaatje Aerts, Marc Faes, Christel et al.

Source: Risk Analysis: An International Journal. Apr2008, Vol. 28 Issue 2, p427-440. 14p. 1 Diagram, 7 Charts, 5 Graphs.

Identification of Salmonella high risk pig-herds in Belgium by using semiparametric quantile regression.

Authors: Bollaerts, Kaatje Aerts, Marc Ribbens, Stefaan et al.

Source: Journal of the Royal Statistical Society: Series A (Statistics in Society). Apr2008, Vol. 171 Issue 2, p449-464. 16p. 4 Charts, 4 Graphs.

Simple and multiple P-splines regression with shape constraints.

Authors: Bollaerts, Kaatje Eilers, Paul H. C. Mechelen, Iven

Source: British Journal of Mathematical & Statistical Psychology. Nov2006, Vol. 59 Issue 2, p451-469. 19p.

Subjects: Regression analysis, Mathematical statistics, Analysis of variance, Factor analysis, Multivariate analysis, Algorithms

Quantile regression with monotonicity restrictions using P-splines and the L1-norm.

Authors: Bollaerts, Kaatje Eilers, Paul H. C. Aerts, Marc

Source: Statistical Modelling: An International Journal. 2006, Vol. 6 Issue 3, p189-207. 19p. 2 Charts, 7 Graphs.

ADVANCE system testing: Benefit-risk analysis of a marketed vaccine using multi-criteria decision analysis and individual-level state transition modelling.

Authors: Bollaerts, Kaatje Ledent, Edouard de Smedt, Tom et al.

Source: Vaccine. 2020 Supplement 2, Vol. 38, pB65-B75. 11p.

ADVANCE: Towards near real-time monitoring of vaccination coverage, benefits and risks using European electronic health record databases.

Authors: Bollaerts, Kaatje de Smedt, Tom McGee, Chris et al.

Source: Vaccine. 2020 Supplement 2, Vol. 38, pB76-B83. 8p.

Benefit–Risk Assessment of Vaccines. Part I: A Systematic Review to Identify and Describe Studies About Quantitative Benefit–Risk Models Applied to Vaccines.

Authors: Arlegui, Hugo Bollaerts, Kaatje Salvo, Francesco et al.

Source: Drug Safety. Nov2020, Vol. 43 Issue 11, p1089-1104. 16p.

Benefit-Risk Assessment of Vaccines. Part II: Proposal Towards Consolidated Standards of Reporting Quantitative Benefit-Risk Models Applied to Vaccines (BRIVAC).

Authors: Arlegui, Hugo Bollaerts, Kaatje Bauchau, Vincent et al.

Source: Drug Safety. Nov2020, Vol. 43 Issue 11, p1105-1120. 16p.

Vaccine effectiveness against laboratory-confirmed influenza in Europe – Results from the DRIVE network during season 2018/19.

Authors: Stuurman, Anke L. Bollaerts, Kaatje Alexandridou, Maria et al.

Source: Vaccine. Sep2020, Vol. 38 Issue 41, p6455-6463. 9p.